Nalaganje...
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers
OBJECTIVE: The aim of this study was to summarise the pharmacokinetic findings from eight phase I studies in healthy volunteers given oral AZD5069, a selective small-molecule CXCR2 antagonist. METHODS: 240 healthy volunteers across eight phase I studies received single (0.1–200 mg) or multiple once-...
Shranjeno v:
| izdano v: | Drugs R D |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995788/ https://ncbi.nlm.nih.gov/pubmed/29856004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-018-0236-x |
| Oznake: |
Označite
Brez oznak, prvi označite!
|